Achilles Therapeutics plc

NasdaqCM:ACHL Stock Report

Market Cap: US$44.0m

Achilles Therapeutics plc Company Information

Achilles Therapeutics plc's employee growth, exchange listings and data sources

Key Information

  • Name: Achilles Therapeutics plc
  • Ticker: ACHL
  • Exchange: NasdaqCM
  • Founded: 2016
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$44.039m
  • Shares Outstanding: 41.10m
  • Website: https://www.achillestx.com

Number of Employees

Location

  • Achilles Therapeutics plc
  • 245 Hammersmith Road
  • London
  • Greater London
  • W6 8PW
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ACHLNasdaqCM (Nasdaq Capital Market)YesADR EACH REPR 1 ORD SHS SPONUSUSDMar 2021
698MUN (Boerse Muenchen)YesADR EACH REPR 1 ORD SHS SPONDEEURMar 2021
698DB (Deutsche Boerse AG)YesADR EACH REPR 1 ORD SHS SPONDEEURMar 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/27 07:42
End of Day Share Price 2024/11/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.